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Abstract
Staphylococcus aureus is a major human pathogen and emergence of antibiotic resistance
in clinical staphylococcal isolates raises concerns about our ability to control these infec-
tions. Cell wall-active antibiotics cause elevated synthesis of methionine sulfoxide reduc-
tases (Msrs: MsrA1 and MsrB) in S. aureus. MsrA and MsrB enzymes reduce S-epimers
and R-epimers of methionine sulfoxide, respectively, that are generated under oxidative
stress. In the S. aureus chromosome, there are threemsrA genes (msrA1,msrA2 and
msrA3) and onemsrB gene. To understand the precise physiological roles of Msr proteins
in S. aureus, mutations inmsrA1,msrA2 andmsrA3 andmsrB genes were created by site-
directed mutagenesis. These mutants were combined to create a triplemsrA (msrA1,
msrA2 andmsrA3) and a quadruplemsrAB (msrA1,msrA2,msrA3,msrB) mutant. These
mutants were used to determine the roles of Msr proteins in staphylococcal growth, antibiot-
ic resistance, adherence to human lung epithelial cells, pigment production, and survival in
mice relative to the wild-type strains. MsrA1-deficient strains were sensitive to oxidative
stress conditions, less pigmented and less adherent to human lung epithelial cells, and
showed reduced survival in mouse tissues. In contrast, MsrB-deficient strains were resis-
tant to oxidants and were highly pigmented. Lack of MsrA2 and MsrA3 caused no apparent
growth defect in S. aureus. In complementation experiments with the triple and quadruple
mutants, it was MsrA1 and not MsrB that was determined to be critical for adherence and
phagocytic resistance of S. aureus. Overall, the data suggests that MsrA1 may be an impor-
tant virulence factor and MsrB probably plays a balancing act to counter the effect of MsrA1
in S. aureus.
Introduction
Staphylococcus aureus is an aggressive and versatile pathogen that is responsible for a wide
array of diseases ranging from pyogenic skin infections to complicated life-threatening diseases
such as bacteremia, central nervous system infections, and endocarditis [1,2,3,4]. Treatment of
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S. aureus infections is a great challenge because of the ability of the organism to develop or ac-
quire antibiotic resistance. A widespread use of methicillin and other semi-synthetic penicillins
has led to the emergence of methicillin-resistant S. aureus (MRSA) strains that have become
prevalent both in the hospitals and the community throughout the world [5,6]. Infections by
MRSA strains cause higher mortality and require longer and more expensive medical care than
infections caused by methicillin-sensitive S. aureus [5].
Host phagocytic cells play key roles in determining the extent of bacterial infections. The phago-
cytic cells induce a respiratory burst and produce superoxide anion that serves as a precursor to gen-
erate additional reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), hydroxyl radical,
singlet oxygen, and hypochlorous acid. These highly reactive species lead to the oxidation of DNA,
lipids and proteins. S. aureus produces antioxidant enzymes such as superoxide dismutases, catalase,
alkyl hydroperoxide reductases, etc. to defend itself from the ROS [7]. However, the ROS and other
oxidizing conditions still cause damage to cellular macromolecules. The ROS oxidize the sulfur
atom of protein-boundmethionine residues, resulting in methionine sulfoxide (MetO) that typically
leads to loss of protein function. MetO are reduced back to methionine by methionine sulfoxide re-
ductase (Msr) enzymes that restore normal protein functions [8]. Oxidation of methionine results
in two diastereomeric forms of MetO, R-MetO and S-MetO, which are reduced by two different
Msr enzymes. MsrB is specific for R-MetO whereas MsrA is specific for S-MetO [9,10].
Msr proteins have also been shown to contribute to the virulence of bacterial pathogens
[11,12,13,14,15]. Absence of Msr enzymes reduces the ability of bacterial cells to adhere to eu-
karyotic cells that probably impacts colonization of the host [13,14,16,17]. In the absence of the
Msr enzymes, the integrity of the bacterial surface proteins is compromised and this deficiency
may contribute to the reduced bacterial adherence to eukaryotic cells [13,14,16,17]. In addition,
reduced Msr activity impacts bacterial survival within phagocytic cells [12].
In S. aureus chromosome, there are threemsrA genes (msrA1,msrA2 andmsrA3) and onemsrB
gene [18]. ThemsrA1 andmsrB genes are co-transcribed in S. aureus and their expression is induced
specifically in response to cell wall-active antibiotics [19]. The expression ofmsrA1/msrB occurs at
much higher levels in S. aureus relative to the expression levels ofmsrA2 ormsrA3 genes [20].
In view of multiplemsrA andmsrB genes in S. aureus; with potential roles in virulence [12,21]
and oxidative stress tolerance [18,22], mutations were generated in each of themsrA andmsrB
genes. Subsequently, three uniquemsrmutants were constructed by combining the individual mu-
tants that included anmsrBmutant (lacks ability to reduce R-MetO), a triplemsrAmutant (msrA1,
msrA2,msrA3; lacks ability to reduce S-MetO), and a quadruplemsrABmutant (msrA1,msrA2,
msrA3,msrB; lacks ability to reduce either R- or S-MetO). These mutants were used to determine
the precise roles of Msr proteins in survival of S. aureus under a variety of stress conditions. The
presented data suggest that MsrA2 andMsrA3 play little or no role in staphylococcal protection
from oxidative stress or in mice. However, the role of themsrA1/msrB locus is complex. While lack
of MsrA1 increases the sensitivity of S. aureus to oxidative stress and host immune defense, the lack
of MsrB, to some extent, is actually beneficial to the bacterial organism under these conditions.
Materials and Methods
Ethics statement
Animal studies were approved by the A.T. Still University-Kirksville College of Osteopathic
Medicine’s Animal Care and Use Committee (IACUC protocol # 166).
Bacterial strains, plasmids, antibiotics and growth conditions
The bacterial strains and plasmids used in this study are shown in Table 1. S. aureus cells were
grown in tryptic soy broth (TSB) or tryptic soy agar (TSA) and Escherichia coli cells were
Msr in Staphylococcus aureus
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grown in Luria-Bertani broth or Luria-Bertani agar. Plasmids in E. coli cells were maintained
by adding ampicillin at 100 μg ml-1, kanamycin at 20 μg ml-1, erythromycin at 15 μg ml-1 and
tetracyclin at 10 μg ml-1, when required. S. aureusmutant strains were cultured with kanamy-
cin at 100 μg ml-1, erythromycin at 15 μg ml-1 and tetracyclin at 10 μg ml-1, when required.
DNAmanipulations
Plasmid DNA was isolated using the Qiaprep Miniprep kit (Qiagen Inc). Chromosomal DNA
was isolated using a DNAzol kit (Molecular Research Center) from lysostaphin-treated S. aure-
us cells according to the manufacturer’s instructions. All restriction and modification enzymes
were purchased from Promega. PCR was performed using a Peltier Thermal Cycler-200 system
(MJ research). DNAmanipulations were carried out using standard procedures. Oligonucleo-
tide primers (Table 2) were obtained from Eurofins.
Table 1. Bacterial strains used in this study.
Strains Characteristics Reference
S. aureus RN4220 A restriction minus derivative of S. aureus strain 8325–4 [54]
SH1000 S. aureus strain 8325–4 with functional RsbU [25]
SH1000:msrA1 SH1000 with mutation in the msrA1 gene (KanR) This study
SH1000:msrA2 SH1000 with mutation in the msrA2 gene (TetR) This study
SH1000:msrA3 SH1000 with mutation in the msrA3 gene (ErmR) This study
SH1000:msrA1-B SH1000 with mutation in the msrA1-msrB genes (KanR) This study
SH1000:msrB SH1000 with mutation in the msrB gene (KanR) This study
SH1000:msrA SH1000 with mutation in the msrA1, msrA2 and msrA3 genes (KanR,
TetR, ErmR)
This study
SH1000:msrAB SH1000 with mutation in the msrA1, msrA2, msrA3, and msrB genes
(KanR, TetR, ErmR)
This study
BB270 A homogeneous methicillin resistant S. aureus [26]
BB270:msrA1 BB270 with mutation in the msrA1 gene (KanR) This study
BB270:msrA2 BB270 with mutation in the msrA2 gene (TetR) This study
BB270:msrA3 BB270 with mutation in the msrA3 gene (ErmR) This study
BB270:msrA1-B BB270 with mutation in the msrA1-msrB genes (KanR) This study
BB270:msrB BB270 with mutation in the msrB gene (KanR) This study
BB270:msrA BB270 with mutation in the msrA1, msrA2 and msrA3 genes (KanR,
TetR, ErmR)
This study
BB270:msrAB BB270 with mutation in the msrA1, msrA2, msrA3, and msrB genes
(KanR, TetR, ErmR)
This study
SH1000+pCU1 SH1000 with plasmid pCU1 (CamR) This study
SH1000:msrA
+pCU1
SH1000:msrA with plasmid pCU1 (KanR, TetR, ErmR, CamR) This study
SH1000:msrAB
+pCU1
SH1000:msrAB with pCU1 (KanR, TetR, ErmR, CamR) This study
SH1000:msrA
+msrA1
SH1000:msrA with pCU1-msrA1P-msrA1 (KanR, TetR, ErmR, CamR) This study
SH1000:msrAB
+msrA1
SH1000:msrAB with pCU1-msrA1P-msrA1 (KanR, TetR, ErmR, CamR) This study
SH1000:msrAB
+msrB
SH1000:msrAB with pCU1-msrA1P-msrB (KanR, TetR, ErmR, CamR) This study
ErmR, erythromycin resistant; KanR, kanamycin resistant; TetR, tetracycline resistant; CamR,
chloramphenicol resistant
doi:10.1371/journal.pone.0117594.t001
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Construction ofmsrmutants in S. aureus
Construction of themsrA1 [22],msrA2 [18], andmsrB [23] mutants has been described previously.
To construct a mutation inmsrA1 andmsrB genes simultaneously, flanking regions (left of
msrA1 and right ofmsrB) were PCR amplified and ligated. Briefly, primer pairs P1 and P2 were
used to amplify a 1449 bp DNA fragment (starting 1364 nt upstream of themsrA1 start codon
and going downstream). Another set of primers P3 and P4 were used to amplify an 841 bp
DNA fragment (starting 156 nt downstream of themsrB stop codon and going further down-
stream). These two fragments were ligated in vector pTZ18R [24] which simultaneously
engineered a unique BamHI site between the ligated fragments to which a 1.7 kb kanamycin-
resistance cassette was cloned. This fragment was used to construct a deletion mutant (msrA1-
msrB) in S. aureus utilizing the methodology described previously for the construction of
individualmsrA1 andmsrA2mutants [18,22].
To construct anmsrA3mutant, primers P5 and P6 were used to amplify a 1084 bp DNA
fragment upstream ofmsrA3 (containing 151 nt of the 5’-end of themsrA3 gene and going up-
stream). Another set of primers, P7 and P8, were used to amplify a 1047 bpmsrA3 downstream
fragment (containing 153 nt of the 3’-end of themsrA3 gene and going downstream). These
two fragments were ligated together in vector pTZ18R to generate a unique BamHI restriction
site between the fragments (lacking a significant portion of themsrA3 gene, from nucleotide
position 152–321 with respect tomsrA3 start codon) to which a 1.4 kb erythromycin-resistance
cassette was cloned. The above construct was used as a suicidal plasmid to construct a mutation
in themsrA3 gene utilizing a method described previously [18,22].
For in vitro and in vivo studies, the S. aureus strain SH1000 [25], which is a sigB positive de-
rivative of the S. aureus strain RN450, was used. Since most MRSA strains are naturally resis-
tant to tetracycline and or erythromycin, a S. aureusMRSA strain BB270 [26] (sensitive to
kanamycin, erythromycin and tetracycline) was used to combinemsrmutations for antibiotic
resistance studies. The individualmsrmutants were combined in these two S. aureus strains to





















Msr in Staphylococcus aureus
PLOSONE | DOI:10.1371/journal.pone.0117594 February 13, 2015 4 / 20
generate a triple (mutant ofmsrA1,msrA2, andmsrA3 genes) and a quadruple mutant (mutant
ofmsrA1,msrA2,msrA3, andmsrB).
Determination of Msr activity
Msr activity in the cell free extract of the wild-type and themsrmutants of S. aureus was deter-
mined using 200 μM of Dabsyl-MetO and 20 mMDTT in 50 mM Tris-HCl (pH 7.5) and incu-
bation at 37°C for 30 min, as previously described [18].
Growth kinetics of the wild-type S. aureus and its isogenicmsrmutant
under stress
Mid-exponential phase cultures (OD600 = 0.6) were diluted 50-fold in a nephelo culture flask
(Wheaton) containing 50 ml fresh TSB with a flask-to-medium volume ratio of 6:1. Oxidative
and antibiotic stress conditions were imposed by the addition of H2O2 and oxacillin in TSB to
appropriate concentrations. Bacterial growth was subsequently monitored by incubating the
flask in a shaking incubator (250 rpm) and measuring turbidity of the liquid culture.
Determination of the sensitivity ofmsrAmutants to oxidants and cell wall
inhibitors
The minimum inhibitory concentrations (MICs) for the wild-type and differentmsrmutant
strains of S. aureus were determined as previously described [27,28]. In addition to H2O2, the
following oxidizing agents were used in MIC determination studies: cumene hydroperoxide
that acts as an intracellular source of reactive oxygen species [29], N-ethylmaleimide that oxi-
dizes thiols and increases disulfide bonds in proteins [30], sodium nitroprusside that serves as
a nitric oxide donor [31]; methyl viologen (paraquat) that generates superoxide [31].
Determination of staphyloxanthin production inmsrmutants
S. aureus wild-type and its isogenicmsrmutant strains were grown at 37˚C for 18 h in TSB.
Cells were harvested and washed twice with sterile water and the levels of staphyloxanthin in
these cells were quantified as described previously [28,32].
Phagocytic killing of S. aureus msrmutant
The promyelocytic HL-60 cells (obtained from American Type Culture Collection) were
grown in Iscove’s Modified Dulbecco’s Medium (IMDM) (ATCC) with 10% fetal bovine
serum (Fisher) and treated with 1.3% dimethyl sulfoxide (Fisher) for 5 days to induce their dif-
ferentiation into neutrophil-like cells. The differentiated neutrophils were used for phagocytic
killing using a method described previously [33,34]. In brief, the neutrophils (1X106 cells) were
added with S. aureus cells (2.5X106 CFUs) (MOI 1:2.5) in a 24-well plate. The plate was centri-
fuged at 4000 rpm for 10 min and incubated in a CO2 incubator at 37˚C for 1 h. The superna-
tant was gently aspirated and the neutrophils were lysed by the addition of IMDM containing
0.025% Titron X-100. The number of surviving bacteria was enumerated by making serial dilu-
tions and plating of this lysate on TSA plate.
Adherence ofmsrmutant to A549 lung epithelial cells
Adherence of S. aureus SH1000 strain and its isogenicmsrmutants was determined by infec-
tion of lung epithelial cells as described previously [35,36]. In these experiments, a mixture of
msrmutant and wild-type (60:40 ratio) S. aureus was used to infect the monolayers of A549
Msr in Staphylococcus aureus
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cells. The ratio of the mutants cells adhered to the A549 cells after 1 h was enumerated and
compared to the ratio of the mutants in the mixture used in these adherence assays.
Complementation of triple and quadruple mutants
For complementation studies, the triple mutant was complemented in trans withmsrA1 and
the quadruple mutant was complemented in trans with eithermsrA1 ormsrB gene. ThemsrA1
andmsrB coding regions were cloned immediately downstream of a previously described con-
struct, pCU1-msrA1P [18]. The resulting constructs pCU1-msrA1P-msrA1 or pCU1-msrA1P-
msrB was transferred into S. aureus RN4220 by electroporation and subsequently transduced
into the triple or quadruple mutants. For comparative studies, wild-type SH1000, and the triple
and quadruple mutants were also transformed with the empty plasmid pCU1 [37].
Levels of Protein A in S. aureus cells
Total protein was extracted from lysostaphin treated S. aureus cells, separated by SDS-PAGE,
and transferred to a nitrocellulose membrane. The membrane was blocked with 5% skimmed
milk and incubated with rabbit antibodies conjugated to horseradish peroxidase (Bio-rad). The
membrane was visualized for Protein A using an Opti-4CN substrate kit (Bio-Rad).
Hemolysis bymsr deficient S. aureus
To visualize the hemolysis, 5.0 μl of the overnight cultures of the wild-type S. aureus SH1000
and themsrmutants were spotted on TSA plates with 5% sheep blood agar and the plate was
incubated at 37°C for 48 h.
Survival of wild-type andmsrmutants in a murine systemic infection
model
Wild-type andmsrmutants were mixed together and then tested in a murine systemic infec-
tion model to determine if these mutations had an effect on the ability of the organism to sur-
vive in vivo as described previously [28,36]. A 0.5 ml mixture of the wild-type andmsrmutant
cells (~1X108 CFU, approximately 40:60 ratio of the wild-type and mutant) was injected into
the peritoneal cavity of Swiss white Hla (ICR)CVF female mice (16–20 g) (Hilltop Lab Ani-
mals, Inc.) and the fraction of mutants surviving in the spleen and liver of infected mice was
enumerated relative to wild-type S. aureus as described previously [28,36].
Localization of S. aureusMsrA1 and MsrB
To determine the localization of MsrA1 and MsrB in S. aureus, wild type S. aureus SH1000 cul-
ture was grown in TSB to an OD600 = 0.3 and treated with 1.2 μg ml
-1 oxacillin for 2.5 h to in-
duce the synthesis of these proteins as described previously [19,22]. Bacterial cells were
harvested and the cytosolic and the cytoplasmic membrane fractions were prepared as de-
scribed previously [38], separated by 15% SDS-PAGE and subjected to western blot analysis
for the presence of MsrA1 and MsrB.
Statistical analysis
Data were analyzed with a paired t-test using a statistical analysis computer program (R for
Windows, version 3.0.2, The R Foundation for Statistical Computing). Statistical significance
was set at p.05.
Msr in Staphylococcus aureus
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Results
Construction of themsrmutants
We previously reported the construction and findings of themsrA1,msrA2, andmsrBmutants
where the phenotypes of the mutant strains were restored by complementation of the mutated
genes in trans [18,22,23]. ThemsrA1 andmsrB genes in S. aureus are the first and second of a
four-gene operon [18,22]. Also, themsrA1mutant produced a significantly higher level of
MsrB relative to wild-type S. aureus [18]. In this study, a mutant was created where the entire
msrA1 andmsrB gene segments were deleted from the bacterial chromosome and replaced
with a kanamycin-resistance cassette to generate anmsrA1-msrB null mutant. AnmsrA3 dele-
tion mutant was also constructed. Subsequently, the threemsrA (msrA1,msrA2,msrA3) mu-
tants were combined to generate an MsrA-deficient triple mutant. In addition, themsrA2
andmsrA3 individual mutants were combined with anmsrA1-msrBmutant to generate a
quadruple mutant. These mutations were verified by PCR using primer pairs flanking the
region that had been deleted in the mutants and replaced by larger antibiotic resistance cas-
settes (Fig. 1).
Msr activity in wild-type andmsrmutants of S. aureus
Cell-free protein extracts from the wild-type andmsrmutant cultures were used to determine
Msr activity using dabsyl-MetO as a substrate. The Msr activity in various mutants was nor-
malized against the enzymatic activity in the wild-type S. aureus SH1000 and the data are
shown in Table 3. The data demonstrate that the MsrA2 and MsrA3 contribute little to the en-
zymatic activity in S. aureus cells (Table 3). An increase in Msr activity in themsrA1mutant is
because of a higher production of MsrB in this mutant [18]. Further, MsrB is responsible for
most of the enzymatic activity (~83%) in wild-type S. aureus SH1000 (Table 3). There was no
enzymatic activity noted in the quadruplemsrABmutant (Table 3).
Fig 1. Confirmation of mutations inmsr genes. Primers from the regions flanking the site of the antibiotic-resistance cassette were used in the PCR.
A `larger PCR product was observed when genomic DNA from the mutant (even-numbered lanes) was used compared to when wild-type genomic DNA was
used (odd-numbered lanes) as a template because of the insertion of a larger antibiotic-resistance cassette. Primers P9 and P10 were used to verify
mutation inmsrA1 (Lanes 1 & 2), P11 and P12 for mutation inmsrA2 (Lanes 3 & 4), P13 and P14 for mutation inmsrA3 (Lanes 5 & 6), P15 and P16 for
mutation inmsrB (Lanes 7 & 8), and P17 and P18 for mutation inmsrA1-B (Lanes 9 & 10). Lane M—DNA ladder.
doi:10.1371/journal.pone.0117594.g001
Msr in Staphylococcus aureus
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Oxidative and antibiotic stress tolerance of themsrmutants
In growth kinetic experiments, the mutants specifically lacking MsrA1 or all three MsrA proteins
showed slightly slower growth rate in TSB at 37°C (Fig. 2). Deletion ofmsrA2,msrA3,msrB, or
msrA1-msrB had no apparent effect on the growth of the mutant cell compared to the growth of
the wild-type S. aureus SH1000 (Fig. 2). When the Msr deficient mutants were cultured in TSB
Table 3. Methionine sulfoxide reductase activity levels in different msr mutants relative to wild-type
S. aureus strain SH1000.










Fig 2. Growth curve of the wild-type S. aureus strain and its derivativemsrmutants in TSB. Values
indicate the average of two independent experiments.
doi:10.1371/journal.pone.0117594.g002
Msr in Staphylococcus aureus
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supplemented with 4.4 mMH2O2, the S. aureus strains lacking MsrA1 failed to grow (Fig. 3A).
In the case of the combinatorial mutants, no growth was recorded for the triplemsrAmutant
even after 16 h in TSB with 8.8 mMH2O2 (Fig. 3B). The amount of H2O2 was raised to 8.8 mM
in growth studies utilizing the combinatorial mutants to assess the resistance of MsrB-deficient
S. aureus relative to other strains (Fig. 3B). The S. aureus strains that lackedMsrB (msrB,msrA1-
msrB and the quadruplemsrABmutants) were moderately resistant to the presence of H2O2 in
these growth experiments (Fig. 3B). The MsrB-deficient strains of methicillin-resistant S. aureus
BB270 demonstrated better growth even in the presence of a cell wall-active antibiotic, oxacillin
(Fig. 3C). In the MIC studies, the S. aureus strains deficient in MsrB were more resistant to H2O2
(Table 4). A similar increase in resistance to oxacillin and other cell wall-active antibiotics was
observed in the case of MsrB-deficient S. aureus (Table 5). The strains that lacked MsrA1 were
susceptible to oxidative stress conditions and the S. aureus strain that lacked all three MsrA pro-
teins (the triplemsrAmutant) showed most sensitivity to oxidants (Table 4). No such increase in
sensitivity was noted in MsrA-deficient S. aureus to cell-wall active antibiotics (Table 5).
Fig 3. Growth of the wild-type S. aureus strain and its derivativemsrmutants in the presence of H2O2 or oxacillin. (A) growth in the presence of
4.4 mM H2O2, (B) growth in the presence of 8.8 mM H2O2 (C) growth in the presence of 400 μg ml
-1 of oxacillin. Values indicate the average of two
independent experiments.
doi:10.1371/journal.pone.0117594.g003
Table 4. Susceptibilities of S. aureus parental strain SH1000 and its derivative msr mutants to oxidants. MIC values indicate average mM
concentrations of three independent experiments.
Strains H2O2 CHPO NEM SNP Paraquat
Wild-type SH1000 1 9.5 0.625 250 125
SH1000:msrA1 0.5 4.75 0.313 7.81 125
SH1000:msrA2 1 9.5 0.625 250 125
SH1000:msrA3 1 9.5 0.625 250 125
SH1000:msrB 2 9.5 0.625 250 125
SH1000:msrA1-B 0.5 9.5 0.625 125 125
SH1000:msrA 0.25 2.38 0.313 1.95 31.25
SH1000:msrAB 0.5 9.5 0.625 250 125
Abbreviations: H2O2, hydrogen peroxide; CHPO, cumene hydroperoxide; NEM, N-ethylmaleimide; SNP, sodium nitroprusside.
doi:10.1371/journal.pone.0117594.t004
Msr in Staphylococcus aureus
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Production of staphyloxanthin pigment inmsrmutants
Of the sevenmsrmutants used in this study, production of staphyloxanthin pigment was
highest in themsrBmutant strain (Fig. 3). The level of staphyloxanthin was lower in MsrA1-
deficient strains (Fig. 3). The MsrA1-deficient S. aureus has been shown to produce a much
higher level of MsrB [18]. Increased pigmentation in MsrB-deficient S. aureus and reduced pig-
mentation in cells producing a higher level of MsrB suggests that the MsrB protein suppresses
the production of staphyloxanthin in S. aureus. Production of staphyloxanthin inmsrA2 and
msrA3mutants was not affected relative to wild-type S. aureus (Fig. 4).
Table 5. Susceptibilities of S. aureus BB270 parental and msr mutant strains to cell wall-active antibiotics.
Strains Oxacillin D-cycloserine Bacitracin
Wild-type BB270 200 75 50
BB270:msrA1 200 75 50
BB270:msrA2 200 75 50
BB270:msrA3 200 75 50
BB270:msrB 400 150 100
BB270:msrA1-B 300 100 75
BB270:msrA 200 75 50
BB270:msrAB 200 75 50
MIC values (μg ml-1) indicate average of three independent experiments.
doi:10.1371/journal.pone.0117594.t005
Fig 4. Production of staphyloxanthin in the wild-type S. aureus strain SH1000 and its derivativemsr
mutants. -The bottom panel shows the color of the bacterial cell pellet from 50 ml overnight grown cultures.
The amount of the staphyloxanthin pigment produced by these cells was quantified and is shown as A462.
Values indicate the average of three independent experiments ± standard deviation (* significant at p.05).
doi:10.1371/journal.pone.0117594.g004
Msr in Staphylococcus aureus
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Phagocytic killing of the S. aureus msrmutant cells
Polymorphonuclear cells utilize oxygen-dependent bactericidal pathways in the phagolyso-
somes. The impact of Msr deletion was investigated on staphylococcal survival in differentiated
polymorphonuclear cells. In these studies, the S. aureus strains with a non-functional MsrA1
showed increased susceptibility to the polymorphonuclear cells (Fig. 5). The survival of the
msrA2,msrA3,msrB ormsrA1-Bmutants of S. aureus was comparable to the wild-type S. aure-
us SH1000 in these assays (Fig. 5).
Role of Msr proteins in adherence of S. aureus to lung epithelial cells
The mixture that was used in adherence assays was biased for anmsrmutant (~60%) relative
to the wild-type S. aureus SH1000 (~40%). In experiments investigating the adherence of this
mixture to A549 cells, the MsrA1-deficient mutants (msrA1,msrA andmsrAB) showed signifi-
cantly reduced adherence (Fig. 6). Deficiency of MsrA2, MsrA3, or MsrB did not impact the
adherence of the S. aureus cells to A549 cells (Fig. 6).
Protein A levels inmsrmutants
Staphylococcal surface protein, Protein A, contributes to bacterial adhesion, virulence, and bio-
film formation. In Western blot analysis involving total protein extract from wild-type S. aure-
us SH1000 and the derivativemsrmutant cells, an apparent 55 kDa protein specific to Protein
A was detected (Fig. 7). Individualmsr gene deletions had no appreciable impact on the levels
Fig 5. Survival of the wild-type S. aureus strain SH1000 and its derivativemsrmutant cells exposed to
polymorphonuclear (PMN) cells. PMN cells were infected (MOI 1:2.5) with wild-type S. aureus SH1000 and
its isogenicmsrmutants for 1 h at 37˚C and then plated on TSA for enumeration. Values indicate the average
of three independent experiments ± standard deviation (* significant at p.05).
doi:10.1371/journal.pone.0117594.g005
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of Protein A in S. aureus (Fig. 7). However, the protein A-specific band was significantly lighter
in the lane corresponding to the triplemsrAmutant (Fig. 7, Lane 7).
Hemolytic pattern ofmsrmutants
In qualitative assays, the S. aureus strain that lacked all three MsrA proteins showed a relatively
smaller zone of beta-hemolysis relative to other strains (Fig. 8, Spot 7). Another interesting ob-
servation was the presence of a significantly reduced secondary zone of hemolysis for the triple
mutant (Fig. 8, Spot 7).
Fig 6. Adherence of the wild-type S. aureus strain SH1000 and its derivativemsrmutant cells to A549
human lung epithelial cells. A total of 5X105 bacterial cells were used in these assays. The left light bar in
each panel represents the ratios of themsrmutant relative to wild-type SH1000 in the mixture used to infect
the A549 cells. The right dark bar in each panel represents the ratios of themsrmutant in the mixture that
adhered to the A549 cells after 1 h of incubation. Values indicate the average of three independent
experiments ± standard deviation (* significant at p.05).
doi:10.1371/journal.pone.0117594.g006
Fig 7. Western analysis of the levels of staphylococcal Protein A in wild-type S. aureus strain SH1000
and its derivativemsrmutants. Top panel shows the total protein profile of wild-type and themsrmutant
strains after SDS-PAGE suggesting that similar amounts of protein were used in the analysis of Protein
A. The bottom panel shows the reactivity of Protein A (arrow) in each lane.
doi:10.1371/journal.pone.0117594.g007
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Hemolysis, phagocytic survival and adherence of complemented triple
and quadruple mutants
The triple SH1000:msrAmutant showed a defective pattern in hemolysis but its complementa-
tion with themsrA1 gene in trans was shown to restore the level of hemolysis shown with the
wild-type SH1000 (Fig. 9A, Spot 3). In phagocytic killing assays, the triple SH1000:msrA and
the quadruple SH1000:msrABmutants were more sensitive than the wild-type SH1000. In
complementation experiments, when triple and quadruple mutants were complemented with
themsrA1 gene in trans, these strains showed phagocytic resistance that was comparable to
wild-type SH1000 (Fig. 9B). However, complementation of the quadruple mutant with the
msrB gene in trans did not restore the phagocytic resistance in these strains (Fig. 9B). Similarly,
in adherence experiments, complementation withmsrA1 gene in trans, restored the defect in
adherence that was initially seen in case of the triple or quadruple mutants (Fig. 9C). Comple-
mentation withmsrB, on the other hand, had no appreciable effect on the adherence of the
quadruple effect (Fig. 9C).
Survival ofmsrmutants in mice
To elucidate the role of Msr in virulence of S. aureus, Swiss white female mice were injected
with a bacterial mixture of wild-type S. aureus SH1000 and its derivative sevenmsrmutants
(40:60 ratio of wild-type to mutant). The data suggest that themsrA1mutant of S. aureus had a
lower survival rate in mice. Post infection, the fraction ofmsrA1mutants in spleen and liver
was lower at 8 h and declined even further at 24 h in these tissues relative to their fraction in
the mixture that was injected into the mice (Fig. 10). Loss of MsrA2, MsrA3, or MsrB had little
to no effect on the survival of S. aureus in mice (Fig. 10). The triplemsrAmutant showed the
highest decline in spleen and liver tissues with time suggesting some roles for MsrA2 and
Fig 8. Hemolytic pattern of the wild-type S. aureus strain SH1000 and its derivativemsrmutants after
48 h of growth on 5% sheep blood agar plates. (1) Wild-type SH1000, (2) SH1000:msrA1, (3) SH1000:
msrA2, (4) SH1000:msrA3, (5) SH1000:msrB, (6) SH1000:msrA1-B, (7) SH1000:msrA, (8) SH1000:msrAB.
doi:10.1371/journal.pone.0117594.g008
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MsrA3 under MsrA1-deficient conditions (Fig. 10). Although, there is a slight growth defect in
themsrA1 and triplemsrAmutants as shown in Fig. 2, when cultured at 37°C in vitro, it is
highly unlikely that there was much of a growth of the wild-type or the mutant bacteria in mice
during our experiments that lasted only 24 h. Most of the bacteria that were injected were
cleared in mice with time, as we recovered fewer bacteria after 8 h and far fewer bacteria after
24 h. It is indeed the lack of MsrA1 that significantly reduced the survival of S. aureus in mice.
Localization ofmsr protein
Localization was only investigated for MsrA1 and MsrB proteins because these two proteins
have been shown to be expressed in S. aureus at a significantly higher level relative to MsrA2
and MsrA3 in S. aureus [20]. In addition, findings of this study suggest that the lack of MsrA1
or MsrB has a pleiotropic effect on S. aureus cells. Experiments utilizing anti-MsrA1 and anti-
MsrB rabbit polyclonal antibodies demonstrated that the MsrA1 protein is distributed equally
between the cytosolic and the membrane components in S. aureus (Fig. 11, Lanes 1 and 2).
Fig 9. Hemolysis (A), phagocytic survival (B) and adherence (C) of complemented triple and quadruple mutants. A. Hemolysis on 5% sheep blood
agar plates. (1) SH1000+pCU1, (2) SH1000:msrA+pCU1, (3) SH1000:msrA+msrA1. B. PMN cells were infected (MOI 1:2.5) with wild-type, mutants, and the
complemented strains for 1 h at 37˚C and then plated for enumeration. (1) SH1000+pCU1, (2) SH1000:msrA+pCU1, (3) SH1000:msrAB+pCU1, (4) SH1000:
msrA+msrA1, (5) SH1000:msrAB+msrA1, (6) SH1000:msrAB+msrB. Values indicate the average of three independent experiments ± standard deviation (*
significant at p.05). C. The left light bar in each panel represents the ratios of the mutant or the complemented strain relative to SH1000-pCU1 in the mixture
used to infect the A549 cells. The right dark bar in each panel represents the ratios of the mutant or the complemented strain in the mixture that adhered after
1 h of incubation. (1) SH1000:msrA+pCU1, (2) SH1000:msrAB+pCU1, (3) SH1000:msrA+msrA1, (4) SH1000:msrAB+msrA1, (5) SH1000:msrAB+msrB.
Values indicate the average of three independent experiments ± standard deviation (* significant at p.05).
doi:10.1371/journal.pone.0117594.g009
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However, the MsrB protein appears to be predominantly a cytosolic protein and only a minor
fraction of this protein is targeted into the bacterial membrane (Fig. 11, Lanes 3 and 4).
Discussion
Numerous investigations in recent years have led to an increased interest and understanding of
the biology of the methionine sulfoxide reductases. The reasons underlying this interest are be-
cause of a remarkable conservation across prokaryotes and eukaryotes, the importance in oxi-
dative stress, and the novel protein repair functions of these enzymes. The two distinct Msr
proteins, MsrA and MsrB, share no sequence homology. Orthologs ofmsrA andmsrB show
great variation in their genetic organization in bacterial chromosomes. In some bacterial spe-
cies, the genes encoding MsrA and MsrB are located adjacent to each other and co-transcribed,
and in others, themsrA andmsrB genes are transcriptionally fused [17,39]. In addition, many
bacterial species have multiple copies of thesemsrA andmsrB genes distributed randomly in
the bacterial chromosome and some are present even on plasmids [39].
Fig 10. Survival of the wild-type S. aureus strain SH1000 and its derivativemsrmutant cells in mouse. Approximately 1.0X108 CFUs (predominantly
mutant cells) were injected intra-peritoneally into mice. Three mice were sacrificed at 8 and 24 h post-injection. Closed circles represent the fraction of wild-
type SH1000 and the open circles represent themsrmutant bacteria recovered frommurine spleens (A) and murine livers (B) at 8 and 24 h post infection.
Values at 0 h indicate the fraction ofmsrmutants and isogenic wild-type cells in the injected inoculum. Values indicate the average of three independent
experiments ± standard deviation (* significant at p.05).
doi:10.1371/journal.pone.0117594.g010
Fig 11. Distribution of MsrA1 and MsrB in the cytosolic andmembrane fractions in S. aureus SH1000.
Lane 1 indicates the cytosolic fraction and Lane 2 indicates the membrane fraction.
doi:10.1371/journal.pone.0117594.g011
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S. aureus produces three different MsrA proteins (MsrA1, MsrA2 and MsrA3) and one
MsrB protein. MsrA1 and MsrB production in S. aureus are induced by cell wall-active antibi-
otics. In the presence of these antibiotics, the cell wall is likely destabilized and the oxidizing
agents have easy access to bacterial membrane and cytosolic compartments. In response, the
staphylococcal cells produce a higher level of MsrA1 and MsrB; however, oxidative stress has
not been shown to induce the synthesis of these proteins in S. aureus. In addition to these four
Msr proteins, there is an additional gene (fRMsr) in S. aureus (SACOL1768 in S. aureus strain
COL) that codes for a protein that reduces the free methionine sulfoxide. Although the struc-
tural and biochemical properties of this protein have been determined [40], its physiological
relevance is unclear. The extent of expression of S. aureus fRMsr is also not clear. The fRMsr
gene in S. aureusmay be expressed at a very low level since there was no detectable Msr activity
in themsrAB quadruple mutant (Table 3).
Studies with the individualmsr gene mutants make it clear that the MsrA2 and MsrA3 con-
tribute little to cellular Msr activities, play a little to no role in protecting S. aureus from oxida-
tive stress and neutrophils, and have no impact on bacterial survival in mice. Using promoter
fusion experiments, we have previously shown thatmsrA2 andmsrA3 are expressed at signifi-
cantly lower levels compared to the expression of themsrA1-msrB locus in S. aureus [20]. We
also measured the relative transcript levels of themsrA2 andmsrA3 relative to the transcript
level ofmsrA1 in S. aureus. The expression level ofmsrA2 was 8–10 log lower compared to
msrA1, and themsrA3-specific transcript was almost absent in a qRT-PCR assay (data not
shown). In a previous study, with promoter reshuffling, we showed that the MsrA2 protein was
as effective as MsrA1 in protection from oxidative stress when its expression level was raised in
S. aureus [18]. ThemsrA3 gene may also be under the influence of a weaker promoter com-
pared to the strength of the promoter that drives the transcription of themsrA1-msrB genes in
S. aureus.
In contrast to MsrA2 and MsrA3, lack of either MsrA1 or MsrB showed pleiotropic effects
in S. aureus. The lack of MsrA1 increased the sensitivity of S. aureus to oxidative stress. Studies
with a triplemsrAmutant, which lacked all three MsrA proteins and therefore had no apparent
capability to reduce S-MetO, showed a further increase in bacterial sensitivity to oxidants com-
pared to only MsrA1-deficient S. aureus. This phenomenon suggests that, even though MsrA2
and MsrA3 are present at very low levels in S. aureus, they may be somewhat relevant in pro-
tecting S. aureus under MsrA1-deficient conditions. The triplemsrAmutant also showed re-
duced hemolysis and increased susceptibility to neutrophil-mediated killing. This observation
was expected given that MsrA deficiency in several organisms leads to enhanced vulnerability
to oxidative stress [18,41,42,43]. In addition, themsrA1 gene was up-regulated in neutrophils
[12]. Within the neutrophils, the staphylococcal two-component regulatory system VraSR con-
tributes to themsrA1 up-regulation [12].
The MsrA1-deficient strains showed reduced pigmentation compared to the wild-type
S. aureus. It has been previously shown that the staphyloxanthin pigment plays an important
role in the protection of S. aureus from oxidants and neutrophils and regulates bacterial mem-
brane fluidity and virulence [44,45,46,47]. In this study, the MsrB-deficient S. aureus strains
were more pigmented and more resistant to H2O2 and cell wall-active antibiotics. One possible
explanation for this phenomenon is that an increased pigmentation in the MsrB-deficient
S. aureusmay contribute to an impermeable membrane that restricts the oxidants and antibiot-
ics. In turn, this change may minimize damage to cellular components under these adverse
conditions. We also noted that the MsrA1-deficient S. aureus or S. aureus that was deficient in
all three MsrA proteins were less adherent to human lung epithelial cells and showed reduced
survival in mouse spleen and liver. The quadruplemsrABmutant of S. aureus also showed re-
duced adherence to A549 cells and survival in mouse tissues. Furthermore, the
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complementation experiments with the triple and quadruple mutants provide evidence that it
is the MsrA1 not MsrB that is critical for staphylococcal adherence to eukaryotic cells and its
resistance to the killing by phagocytic cells.
With respect to the role of the Msr proteins, it is well documented that these enzymes con-
tribute to the ability of a pathogen to adhere to host tissue, evade immune system, form bio-
films, survive inside macrophages, and resist oxidative killing [14].MsrA protein contributes to
cell wall integrity and maintenance of adhesion properties in Streptococcus gordonii [48]. Msr
proteins have also been shown to affect adherence properties of pathogenic Neisseria [17]. In
S. gordonii, the MsrA enzyme was shown to maintain the integrity of bacterial adhesins during
oxidative stress [49]. The current study confirms the role of Msr proteins, particularly the
MsrAs in the adherence of S. aureus to human cells. The MsrA1-deficient S. aureus, the triple
msrA and the quadruplemsrAB null-mutants, all showed reduced adherence to lung epithelial
cells. The role of Msr proteins in virulence of the bacterial pathogens is also well documented.
Both MsrA and MsrB contributed to the enzymatic defenses ofMycobacterium tuberculosis
from reactive oxygen species [50]. In Pseudomonas aeruginosa, inactivation of eithermsrA or
msrB or both reduced virulence and increased its killing by oxidants [51]. In Campylobacter
jejuni, the singlemsrA ormsrBmutants showed no growth defect, but themsrA-msrB double
mutant showed increased sensitivity to oxidative stress conditions [31]. Mutation in themsrA
ormsrB gene in Enterococcus faecalis resulted in increased sensitivity to H2O2. In addition, an
msrA msrB double mutant showed further increase in sensitivity suggesting that the effect of
mutations were additive [15]. In a later study, however, themsrA andmsrBmutants were
shown to behave differently; themsrAmutant was more sensitive to oxidative stress conditions
whereas themsrBmutant showed stimulated growth under similar conditions [52]. In Salmo-
nella Typhimurium, deletion ofmsrA increased bacterial susceptibility to H2O2 and reduced its
virulence, but a mutation inmsrB had no apparent phenotype [11]. InMycobacterium smeg-
matis also, MsrB was shown to have a limited role in protection from oxidative stress condi-
tions [53].
Thus, the role of MsrB protein in defense from oxidative stress is questionable in many bac-
terial species. It is possible that under oxidative stress the majority of the oxidized methionine
is S-MetO and the MsrB protein has no activity against this epimer. This may be the reason
why the MsrA-deficient bacteria showed a high sensitivity to conditions that impose oxidative
stress. MsrB of S. aureus, seems to some extent, counterbalance the effect of MsrA1. For exam-
ple, lack of MsrA1 reduces pigmentation and this may be due to previously shown higher level
of MsrB in MsrA1-deficient S. aureus [18]. However, when MsrB is absent, the bacterium re-
sponds by increasing pigment production as a potential compensatory mechanism.
In summary, among the four Msr enzymes produced in S. aureus, MsrA2 and MsrA3 con-
tribute little to the enzymatic activity and bacterial defense from oxidative stress. MsrA1 and
MsrB have opposing roles in pigment production and resistance from oxidative stress. MsrA1
seems to be equally distributed between the cytosolic and membrane components but the
MsrB appears to be predominantly cytosolic. Regulation ofmsrA1-msrB locus is currently
under investigation because of its significant role in S. aureus physiology and virulence.
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